Literature DB >> 21751735

Cardiovascular prevention and rehabilitation for patients with ventricular assist device from exercise therapy to long-term therapy. Part I: Exercise therapy.

Ugo Corrà1, Massimo Pistono, Alessandro Mezzani, Marco Gnemmi, Franco Tarro Genta, Roberto Caruso, Pantaleo Giannuzzi.   

Abstract

In the present context of an aging population, limited donor heart availability, improved reliability of mechanical cardiac support and improved patient outcomes, ventricular assist device (VAD) options to support end-stage heart failure patients are rapidly expanding. In addition, both the smaller size and lighter weight of the pumps now produced and early evidence that these third generation devices may be associated with lower risk of infection and right ventricular failure will probably lead to greater physician and patient acceptability. This is the first of a two-part review on the role of cardiovascular prevention and rehabilitation in patients with VAD. In this first part, we will discuss the role of exercise therapy in VAD patients, while the second will focus on long-term management. One of the prerequisites for use of a VAD--whether permanent (as destination therapy) or semi-permanent (as an alternative to heart transplantation)--is that exercise capacity, although not normal, must be adequate for daily life activities. An intensive multidisciplinary rehabilitation program has the potential to increase exercise performance and improve the quality of life of VAD patients. Both early progressive mobilization and exercise training may improve the overall condition of VAD patients, and favorably impact their clinical course.

Entities:  

Mesh:

Year:  2011        PMID: 21751735     DOI: 10.4081/monaldi.2011.203

Source DB:  PubMed          Journal:  Monaldi Arch Chest Dis        ISSN: 1122-0643


  6 in total

1.  Exercise rehabilitation in ventricular assist device recipients: a meta-analysis of effects on physiological and clinical outcomes.

Authors:  Liza Grosman-Rimon; Spencer D Lalonde; Nina Sieh; Maureen Pakosh; Vivek Rao; Paul Oh; Sherry L Grace
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

2.  Exercise Performance During the First Two Years After Left Ventricular Assist Device Implantation.

Authors:  Christiane Marko; Endri Xhelili; Thomas Lackner; Daniel Zimpfer; Heinrich Schima; Francesco Moscato
Journal:  ASAIO J       Date:  2017 Jul/Aug       Impact factor: 2.872

3.  Effect of left ventricular assist device implantation and heart transplantation on habitual physical activity and quality of life.

Authors:  Djordje G Jakovljevic; Adam McDiarmid; Kate Hallsworth; Petar M Seferovic; Vladan M Ninkovic; Gareth Parry; Stephan Schueler; Michael I Trenell; Guy A MacGowan
Journal:  Am J Cardiol       Date:  2014-04-18       Impact factor: 2.778

4.  Exercise therapy for an older patient with left ventricular assist device.

Authors:  Won Hah Park; Yong Gon Seo; Ji Dong Sung
Journal:  Ann Rehabil Med       Date:  2014-06-26

5.  HFA of the ESC position paper on the management of LVAD-supported patients for the non-LVAD specialist healthcare provider Part 3: at the hospital and discharge.

Authors:  Finn Gustafsson; Binyamin Ben Avraham; Ovidiu Chioncel; Tal Hasin; Avishai Grupper; Aviv Shaul; Sanemn Nalbantgil; Yoav Hammer; Wilfried Mullens; Laurens F Tops; Jeremy Elliston; Steven Tsui; Davor Milicic; Johann Altenberger; Miriam Abuhazira; Stephan Winnik; Jacob Lavee; Massimo Francesco Piepoli; Lorrena Hill; Righab Hamdan; Arjang Ruhparwar; Stefan Anker; Marisa Generosa Crespo-Leiro; Andrew J S Coats; Gerasimos Filippatos; Marco Metra; Giuseppe Rosano; Petar Seferovic; Frank Ruschitzka; Stamatis Adamopoulos; Yaron Barac; Nicolaas De Jonge; Maria Frigerio; Eva Goncalvesova; Israel Gotsman; Osnat Itzhaki Ben Zadok; Piotr Ponikowski; Luciano Potena; Arsen Ristic; Tiny Jaarsma; Tuvia Ben Gal
Journal:  ESC Heart Fail       Date:  2021-09-28

6.  Short- and long-term effects of a cardiac rehabilitation program in patients implanted with a left ventricular assist device.

Authors:  Anna Scaglione; Claudia Panzarino; Maddalena Modica; Monica Tavanelli; Antonio Pezzano; Paola Grati; Vittorio Racca; Anastasia Toccafondi; Bruno Bordoni; Alessandro Verde; Iside Cartella; Paolo Castiglioni
Journal:  PLoS One       Date:  2021-12-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.